IRAK1 and hepatocellular carcinoma: In addition, IRAK1 have reported that promotes the progression of hepatocellular carcinoma by participating in the chronic inflammation mediated by macrophages, which is consistent with the positive correlation between IRAK1 and macrophage expression in liver cancer found in this study (Li et al., 2015).